“Life sciences companies―from biotech’s to pharma to biomedical device manufacturers―are being buffeted by seismic market shifts. New socioeconomic realities, health care reform legislation and accelerating scientific breakthroughs are building up to a perfect storm.”
The pharmaceuticals and life sciences industry continues to undergo massive change. The consumerization of healthcare, increased competition to the United States’ supremacy, skills shortages and digital disruption are all having an impact.
According to the U.S Bureau of Labor Statistics, $60bn is spent every year on pharmaceutical research and development. Meanwhile, the costs for developing new drugs have drastically increased over the last decades, from under $200m in the 1970s to over $2.6bn today. Fueling this boom has been a lot of bright minds. And the industry needs more.
In February 2018 we commissioned a OnePoll survey of 500 UK-based senior decision makers across a wide range of industries, in companies with 50+ employees.
When it’s time to hire your business will have an idea of why you want to recruit, who you want to bring in and how you’re going to do it. But how effective and efficient are your current processes?
We’re constantly being reminded about skills shortages, the availability or unavailability of talent, cyber security, automation and a whole raft of threats to growth. But while it might seem like there’s no let-up for the C-Suite there are solutions available to reduce these stresses and enable opportunities.
Sign-up for our latest thinking
Fill in the form to get our opinions on the hottest industry topics.